Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China
· Delayed Price · Currency is CNY 39.29
-0.50 (-1.26%)
Apr 28, 2026, 3:00 PM CST
SHA:603392 Revenue
In the year 2025, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 1.82B CNY, down -18.99%. Beijing Wantai Biological Pharmacy Enterprise had revenue of 320.60M in the quarter ending December 31, 2025, with 7.84% growth.
Revenue
1.82B
Revenue Growth
-18.99%
P/S Ratio
25.58
Revenue / Employee
471.74K
Employees
3,790
Market Cap
49.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.82B | -426.44M | -18.99% |
| Dec 31, 2024 | 2.25B | -3.27B | -59.25% |
| Dec 31, 2023 | 5.51B | -5.67B | -50.73% |
| Dec 31, 2022 | 11.19B | 5.43B | 94.51% |
| Dec 31, 2021 | 5.75B | 3.40B | 144.25% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharmaron Beijing | 14.10B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Haisco Pharmaceutical Group | 4.39B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Shanghai RAAS Blood Products | 7.35B |
| Chongqing Zhifei Biological Products | 10.91B |